Back to Stakeholders
Research, Drug Development & ManufacturingLead program: Pre-clinical

Entheos Labs

1 Drug Candidate

Entheos Labs is a Boston-based psychedelic medicines company founded in 2022 by Dr. Jerry Rosenbaum and Tristan Edwards, dedicated to discovering, developing, and deploying novel psychedelic medicines for unmet medical needs. The company is creating a pipeline of new chemical entities derived from overlooked natural psychedelic materials, with its lead candidate ET-01 targeting mood, anxiety, trauma, and substance use disorders.

Drug Pipeline

1

ET-01

Pre-clinical
Depressive DisordersAnxiety DisordersSubstance Use Disorders (SUD)

Synthetic derivative of a novel unscheduled natural product; novel formulation and delivery method for targeted treatment of mental health and substance use disorders.

Quick Facts

Type
Private Biotech
Founded
2022
Lead Stage
Pre-clinical
Website
Visit